Zydus Lifesciences rose 1.03% to Rs 994 after the company announced that it has received final approval from the United States Food and Drug Administration (USFDA) to market Finasteride and Tadalafil capsules USP.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
